Clearmind Medicine
CMND
6 hedge funds and large institutions have $5.49M invested in Clearmind Medicine in 2024 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
1,891% more capital invested
Capital invested by funds: $276K → $5.49M (+$5.22M)
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
100% more funds holding
Funds holding: 3 → 6 (+3)
12.29% more ownership
Funds ownership: 5.01% → 17.3% (+12%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GAM
Gotham Asset Management
New York
|
+$483K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$200K |
| 3 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
+$59.2K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$27.3K |
| 5 |
HF
HRT Financial
New York
|
+$18.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
-$27.9K |
CMND Hedge Fund Activity: Q3 2024 in Review
6 of the 6,982 institutional investors tracked by Wall St. Rank reported a position in Clearmind Medicine (CMND) for Q3 2024, worth a combined $5.49M — up 1,891% from $276K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new CMND positions and 1 closed out — a net gain of 3 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Gotham Asset Management, opening a new position worth an estimated $483K. The largest seller was Geode Capital Management, exiting entirely with an estimated $27.9K sold.
- 6 institutional investors held Clearmind Medicine (CMND) as of Q3 2024, up from 3 in Q2 2024.
- Funds reported $5.49M of Clearmind Medicine stock for Q3 2024, up 1,891% quarter-over-quarter.
- 4 funds opened new Clearmind Medicine positions in Q3 2024 and 1 closed out, a net change of +3 holders.
- The largest Clearmind Medicine buyer in Q3 2024 was Gotham Asset Management, an estimated $483K added.
- The largest Clearmind Medicine seller in Q3 2024 was Geode Capital Management, an estimated $27.9K sold.
Based on aggregated 13F filings for Q3 2024.